Medical cannabis

MGO | ELLO National Cannabis Alliance Releases Special Report on Cannabis IPOs and RTOs

Retrieved on: 
Tuesday, November 13, 2018
Herbalism, Medicinal plants, Medicine, Health, Clinical medicine, Cannabis, Cannabis law, Drug control law, Legality of cannabis, Medical cannabis

The MGO | ELLO National Cannabis Alliance and MNP have served as advisors to numerous US-based cannabis businesses that have successfully gone public in Canada and understand what is needed to successfully complete this journey.

Key Points: 
  • The MGO | ELLO National Cannabis Alliance and MNP have served as advisors to numerous US-based cannabis businesses that have successfully gone public in Canada and understand what is needed to successfully complete this journey.
  • "Going public is a complex capital market transaction that requires significant investment in resources and planning to execute successfully," says Scott Hammon, COO, MGO | ELLO National Cannabis Alliance.
  • "For these complex financial transactions to be successful there are essential priorities and significant changes for the organization to execute both pre- and post-IPO," said Evan Eneman, CEO, MGO | ELLO National Cannabis Alliance.
  • The MGO | ELLO National Cannabis Alliance is part of the Go Public in Canada alliance, a collective of firms that helps US and global cannabis companies publicly list in Canada.

Coda Signature Ranks as a Best Selling Edible and Topical Brand on 2018 LeafLink List

Retrieved on: 
Tuesday, November 13, 2018
Herbalism, Medicinal plants, Medicine, Health, Clinical medicine, Edible, Cannabis, Legality of cannabis, Medical cannabis

DENVER, Nov. 13, 2018 /PRNewswire/ -- Coda Signature , a leading manufacturer of premium, cannabis-infused edibles, topicals and concentrates for medicinal and adult-use, was recognized among the best selling edible and topical brands on the 2018 LeafLink List .

Key Points: 
  • DENVER, Nov. 13, 2018 /PRNewswire/ -- Coda Signature , a leading manufacturer of premium, cannabis-infused edibles, topicals and concentrates for medicinal and adult-use, was recognized among the best selling edible and topical brands on the 2018 LeafLink List .
  • The 2018 LeafLink List captures top performing brands on its b2b e-commerce platform serving twelve states, 700+ cannabis brands and 2,500+ retailers.
  • The LeafLink List compared over 4,000 edible products and nearly 1,000 topical and transdermals across the twelve states where the LeafLink platform is available.
  • "We are thrilled to be recognized as a best selling brand in edibles and topicals," commented Coda Signature's Co-Founder and CEO, Mark Grindeland.

AEssenseGrows Introduces 'the Perfect Grow Light' for Cannabis

Retrieved on: 
Tuesday, November 13, 2018
Medicinal plants, Entheogens, Euphoriants, Herbalism, Medicine, Lighting, Health, Clinical medicine, Grow light, Cannabis, Yellow, Medical cannabis

The lights will be showcased Wednesday through Friday at MJBizCon in Las Vegas at the AEssenseGrows booth, #2473.

Key Points: 
  • The lights will be showcased Wednesday through Friday at MJBizCon in Las Vegas at the AEssenseGrows booth, #2473.
  • "The best quality buds grow under balanced broad-spectrum light--light that contains sufficient amounts of blue, green, yellow, and redand that's what AErix lights deliver.
  • That's why we call them the perfect grow light."
  • Ackrell Capital listed AEssenseGrows as one of the firm's Top 100 Private Cannabis Companies for 2018.

The Global Cannabis Market Continues to Grow as Medical Cannabis Legalization Spreads

Retrieved on: 
Tuesday, November 13, 2018
Cannabis, Herbalism, Medicinal plants, Medicine, Health, Cannabis law, Entheogens, Medical cannabis, Legality of cannabis, Minors and the legality of cannabis, Cannabis in Canada

Recently, Canada legalized cannabis entirely, which has now led many other countries around the world to consider either recreational or medical legalization.

Key Points: 
  • Recently, Canada legalized cannabis entirely, which has now led many other countries around the world to consider either recreational or medical legalization.
  • Although more and more states within the U.S. are beginning to legalize recreational cannabis, the medical segment is still projected to dominate the overall market.
  • Research and development for medical cannabis are still continually evolving which is leading the market to grow at a CAGR of 17.2% during a forecast period, from 2018 to 2023.
  • "As we said, medical marijuana seems to be the path by which societies have been normalizing the use of cannabis."

The Popularity of Recreational Cannabis is Driving the Global Cannabis Market Growth

Retrieved on: 
Tuesday, November 13, 2018
Medicine, Herbalism, Medicinal plants, Health, Cannabis smoking, Cannabis, Antiemetics, Antioxidants, Medical cannabis, Cannabis in the United States, Effects of cannabis, Decriminalization of non-medical cannabis in the United States

Despite the complex regulatory structure at state and federal levels, the rising demand of recreational cannabis in the United States and North America, which accounts for over 49% of the market, is a key factor driving growth in the industry.

Key Points: 
  • Despite the complex regulatory structure at state and federal levels, the rising demand of recreational cannabis in the United States and North America, which accounts for over 49% of the market, is a key factor driving growth in the industry.
  • As more states continue to end the prohibition of cannabis for recreational use, the legal market can only expand even further.
  • Colorado was the first to offer recreational cannabis, and many companies have attempted to solve the cash problem for those businesses.
  • MTrac aims to make San Diego the first cashless and compliant cannabis city as a model for others to follow.

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Premier Sponsor of CannX Brazil Conference; HempMeds® Mexico President Invited as Featured Speaker

Retrieved on: 
Tuesday, November 13, 2018
Medicinal plants, Entheogens, Cannabis, Medicine, Health, Herbs, Euphoriants, Herbalism, Cannabidiol, Hemp, Medical Marijuana, Inc., Medical cannabis

HempMeds Mexico President Raul Elizalde has been invited to be a featured speaker at the conference and will present on the benefits of cannabidiol (CBD) hemp oil and the evolving legal landscape of cannabis in Latin America.

Key Points: 
  • HempMeds Mexico President Raul Elizalde has been invited to be a featured speaker at the conference and will present on the benefits of cannabidiol (CBD) hemp oil and the evolving legal landscape of cannabis in Latin America.
  • "I am honored to be a featured speaker at this incredible educational event," said HempMeds Mexico President Raul Elizalde.
  • Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop .
  • These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets.

Growing Cannabis Industry Creates Space for New Strategies

Retrieved on: 
Tuesday, November 13, 2018
Cannabis, Medicinal plants, Health, Medicine, Entheogens, Euphoriants, Herbalism, Cannabis smoking, Medical cannabis, Effects of cannabis, Cannabis in Canada, Steve DeAngelo

As the cannabis industry continues to grow, companies are using a variety of strategies to secure their places within the sector.

Key Points: 
  • As the cannabis industry continues to grow, companies are using a variety of strategies to secure their places within the sector.
  • This year has seen huge developments for the cannabis industry in North America.
  • This wave of change is leading to staggering growth in the cannabis industry.
  • This is creating a new space for cannabis companies to work in, where new strategies are being tested alongside new products.

Evolab Alchemy Now Available Featuring Delta 8 THC

Retrieved on: 
Tuesday, November 13, 2018
Euphoriants, Entheogens, Medicinal plants, Medicine, Cannabis, Neurochemistry, Appetite stimulants, Antiemetics, Tetrahydrocannabinol, Evolab, Cannabinoid, Medical cannabis

DENVER, Nov. 13, 2018 /PRNewswire/ -- Evolab , a CBx Enterprises brand, today unveiled a special formulation of its customer favorite Alchemy extract rich in Delta 8 THC, a rare cannabinoid that Evolab exclusively offers in Colorado.

Key Points: 
  • DENVER, Nov. 13, 2018 /PRNewswire/ -- Evolab , a CBx Enterprises brand, today unveiled a special formulation of its customer favorite Alchemy extract rich in Delta 8 THC, a rare cannabinoid that Evolab exclusively offers in Colorado.
  • Following the Summer 2018 introduction of the first Delta 8 THC vape in Colorado, Evolab has expanded its Delta 8 offering with the new Alchemy formulations featuring strain specific CO2 extracted cannabis terpenes.
  • Similar to the better known Delta 9 THC, Delta 8 THC is a naturally occurring compound found in most cannabis plants.
  • In order to increase availability of this fascinating cannabinoid, the Evolab team, headed by Chief Scientist Noel Palmer, Ph.D., created a unique distillation process using just heat and filtration to convert regular Delta 9 THC into Delta 8 THC.

Gold Flora Selects Xabis as Processing Operations Partner

Retrieved on: 
Monday, November 12, 2018
Medicinal plants, Medicine, Entheogens, Euphoriants, Herbalism, Health, Clinical medicine, Cannabis, Legality of cannabis, Medical cannabis

"Xabis' proven operations and professional approach in numerous states and Canada ensures Gold Flora continues to deliver the highest quality cannabis in California, and allows us to scale to meet the growing demand here in the Golden State," said Greg Gamet, Gold Flora's Chief Cannabis Officer.

Key Points: 
  • "Xabis' proven operations and professional approach in numerous states and Canada ensures Gold Flora continues to deliver the highest quality cannabis in California, and allows us to scale to meet the growing demand here in the Golden State," said Greg Gamet, Gold Flora's Chief Cannabis Officer.
  • Dale Zink, CEO of Xabis added, "The Gold Flora team consists of top-notch professionals focused on premium quality products.
  • By bringing on Xabis, Gold Flora can concentrate on operations and growing the business, and allow Xabis to focus on processing the highest quality products, with adherence to all rules and regulations."
  • For more information on Gold Flora, visit: www.goldflora.com
    For more information on Xabis, visit: www.xabisinc.com

Valens Receives Updated Health Canada License, Permits B2B Sales

Retrieved on: 
Monday, November 12, 2018
Medicine, Herbalism, Medicinal plants, Cannabis, Health, Pharmaceuticals policy, Drug control law, Legality of cannabis, Medical cannabis, Cannabis in Canada, Cannabis laws of Canada by province or territory

The updated licensing has been issued in accordance with Health Canada's Cannabis Act and Cannabis Regulations, which had previously been issued under the Access to Cannabis for Medical Purposes Regulations ("ACMPR").

Key Points: 
  • The updated licensing has been issued in accordance with Health Canada's Cannabis Act and Cannabis Regulations, which had previously been issued under the Access to Cannabis for Medical Purposes Regulations ("ACMPR").
  • Effective immediately, the Company's wholly owned subsidiary, Valens Agritech Ltd, is authorized to sell cannabis and cannabis products in accordance with subsection 11(5) and 17(5) of the Cannabis Regulations.
  • This updated license from Health Canada allows Valens to engage in business to business (B2B) sales with its strategic partners and other qualified license holders under the Cannabis Act and Cannabis Regulations, including executing on extraction agreements already in place.
  • Subsidiary Valens Agritech ("VAL") holds a standard processing and standard cultivation license class under the Cannabis Act.